EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Back to dashboard
Company Information
About this company
Key people
Charles Alexander Evan Spicer
Non-Executive Independent Chairman of the Board
Ilian Petkov Iliev
Chief Executive Officer, Executive Director
Aneshkumar Ishwarbhai Patel
Group Chief Financial Officer
Edward Hooper
Executive Director, General Counsel
Stephen Crowe
Portfolio CFO, Company Secretary
Jonathan Mark Robinson
Non-Executive and Senior Independent Director
Click to see more
Key facts
- Shares in issue27.97m
- EPICEMVC
- ISINGB00BN4R5Q82
- LocationUnited Kingdom
- SectorFinancial
- IndustryMisc. Financial Services
- Market cap£12.73m
- Employees21
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.